Drugs / ALT005
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01531699 | Feb → Oct 2012 | infectious disease | Altacor Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALT005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01531699 ↗ |
| Route | Topical | “following dermal administration” NCT01531699 ↗ |